Matthew Neal

AcquisitionPrivateMajority

target

Aegerion Pharmaceuticals

bidder

Amryt Pharma

£310m

31 dealmakers

United States

AcquisitionMajorityPrivate

target

Ashfield Pharmacovigilance

bidder

Ergomed

£7m

12 dealmakers

Belgium

Private EquityMinorityVenture CapitalAcquisitionDomesticPrivate

target

Iteos Therapeutics

bidder

The Invus Group

£101m

25 dealmakers

MajorityAcquisitionCross BorderPublic

target

Horizon Discovery Group

bidder

Perkinelmer

£283m

33 dealmakers

MajorityDomesticPrivateAcquisition

Diversified Industrials

target

Raleigh Coatings

bidder

Advanced Medical Solutions Group

£22m

9 dealmakers

Finland

PrivateCross BorderMajorityAcquisition

target

Mobidiag

bidder

Hologic

£579m

38 dealmakers

Belgium

Private EquityAcquisitionMajorityPrivateCross Border

target

Novadip Biosciences

bidder

Cr-cp Life Science Fund

£15m

11 dealmakers

United States

Joint VentureAcquisitionMajorityPrivateCross Border

target

Oxford Biomedica Solutions

bidder

Oxford Biomedica

value n/a

8 dealmakers

United States

PrivateAcquisitionDomesticMajority

target

Homology Medicines (manufacturing And Innovation Business)

bidder

Oxford Biomedica

£63m

42 dealmakers

PrivateDomesticMajorityAcquisition

Diversified Financials

target

Adamas Consulting Group

bidder

Ergomed

£25m

19 dealmakers

AcquisitionMajorityDomesticPublicPrivate Equity

target

Ergomed

bidder

Permira Advisers

£703m

45 dealmakers

France